A. Ganesan

8.4k total citations · 1 hit paper
152 papers, 6.4k citations indexed

About

A. Ganesan is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, A. Ganesan has authored 152 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 117 papers in Molecular Biology, 88 papers in Organic Chemistry and 19 papers in Pharmacology. Recurrent topics in A. Ganesan's work include Chemical Synthesis and Analysis (55 papers), Histone Deacetylase Inhibitors Research (36 papers) and Synthetic Organic Chemistry Methods (25 papers). A. Ganesan is often cited by papers focused on Chemical Synthesis and Analysis (55 papers), Histone Deacetylase Inhibitors Research (36 papers) and Synthetic Organic Chemistry Methods (25 papers). A. Ganesan collaborates with scholars based in United Kingdom, Singapore and Japan. A. Ganesan's co-authors include Haishan Wang, Terence C. S. Ho, Alex H. Y. Chan, Graham Packham, Jean‐Yves Ortholand, Bheemashankar A. Kulkarni, Ángel R. de Lera, Simon J. Crabb, Shijun Wen and Natarajan Srinivasan and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

A. Ganesan

149 papers receiving 6.3k citations

Hit Papers

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
    2020 534 citations A. Ganesan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ganesan United Kingdom 45 3.9k 2.5k 848 744 424 152 6.4k
Liangren Zhang China 39 2.8k 0.7× 2.4k 0.9× 300 0.4× 456 0.6× 510 1.2× 236 6.2k
Michael Gütschow Germany 44 3.3k 0.8× 2.2k 0.9× 891 1.1× 941 1.3× 109 0.3× 281 6.4k
Wolfgang Sippl Germany 57 6.4k 1.6× 1.6k 0.6× 830 1.0× 1.7k 2.3× 584 1.4× 303 10.3k
Hengming Ke United States 47 5.7k 1.5× 1.0k 0.4× 1.4k 1.7× 746 1.0× 271 0.6× 107 8.0k
Mark D. Erion United States 44 3.0k 0.8× 1.3k 0.5× 216 0.3× 524 0.7× 613 1.4× 129 5.4k
Manfred Jung Germany 57 7.4k 1.9× 1.6k 0.6× 549 0.6× 2.1k 2.8× 691 1.6× 291 10.4k
Matthias U. Kassack Germany 48 2.9k 0.7× 1.1k 0.4× 809 1.0× 991 1.3× 1.0k 2.4× 153 5.5k
Billy W. Day United States 52 3.5k 0.9× 2.4k 1.0× 753 0.9× 1.4k 1.8× 90 0.2× 178 7.5k
Jeffrey D. Winkler United States 43 2.5k 0.6× 3.1k 1.2× 404 0.5× 604 0.8× 240 0.6× 149 6.7k
Satoshi Shuto Japan 39 3.1k 0.8× 3.1k 1.2× 298 0.4× 343 0.5× 522 1.2× 329 6.2k

Countries citing papers authored by A. Ganesan

Since Specialization
Citations

This map shows the geographic impact of A. Ganesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ganesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ganesan more than expected).

Fields of papers citing papers by A. Ganesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ganesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ganesan. The network helps show where A. Ganesan may publish in the future.

Co-authorship network of co-authors of A. Ganesan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ganesan. A scholar is included among the top collaborators of A. Ganesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ganesan. A. Ganesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hailu, Gebremedhin Solomon, A. Ganesan, Rossella Fioravanti, et al.. (2025). Tranylcypromine-Based LSD1 Inhibitors as Useful Agents to Reduce Viability of Schistosoma mansoni. ACS Infectious Diseases. 11(8). 2178–2189.
2.
Palmer, Leoni I., et al.. (2025). Interactive Docking Workshop: Docking the Anticancer Drug Belinostat to Its Cellular Histone Deacetylase (HDAC) Target. Journal of Chemical Education. 102(6). 2514–2521. 1 indexed citations
3.
Tammam, Mohamed A., Florbela Pereira, Elizabeth Skellam, et al.. (2025). The cytochalasans: potent fungal natural products with application from bench to bedside. Natural Product Reports. 42(5). 788–841. 2 indexed citations
4.
Ganesan, A., et al.. (2024). Phytochemicals in Drug Discovery—A Confluence of Tradition and Innovation. International Journal of Molecular Sciences. 25(16). 8792–8792. 22 indexed citations
5.
6.
Ahmad, Rizwan, Ignacio Pérez‐Victoria, Jesús Martı́n, et al.. (2022). Euglenatides, Potent Antiproliferative Cyclic Peptides Isolated from the Freshwater Photosynthetic Microalga Euglena gracilis. Angewandte Chemie. 134(23). 1 indexed citations
7.
Ahmad, Rizwan, Ignacio Pérez‐Victoria, Jesús Martı́n, et al.. (2022). Euglenatides, Potent Antiproliferative Cyclic Peptides Isolated from the Freshwater Photosynthetic Microalga Euglena gracilis. Angewandte Chemie International Edition. 61(23). e202203175–e202203175. 15 indexed citations
8.
Girard, Nicolas, et al.. (2020). Three cheers for nitrogen: aza-DKPs, the aza analogues of 2,5-diketopiperazines. RSC Advances. 10(71). 43358–43370. 6 indexed citations
9.
Liang, Liyun, Haiwen Wang, Bingling Luo, et al.. (2020). New tranylcypromine derivatives containing sulfonamide motif as potent LSD1 inhibitors to target acute myeloid leukemia: Design, synthesis and biological evaluation. Bioorganic Chemistry. 99. 103808–103808. 21 indexed citations
10.
Ganesan, A., et al.. (2016). Oral Administration of Peptide‐Based Drugs: Beyond Lipinski's Rule. ChemMedChem. 11(20). 2245–2251. 111 indexed citations
11.
Davies, Elizabeth R., Hans Michael Haitchi, Thomas H. Thatcher, et al.. (2012). Spiruchostatin A Inhibits Proliferation and Differentiation of Fibroblasts from Patients with Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 46(5). 687–694. 50 indexed citations
12.
Lewis, Alexander M., Akiko Mizote, Justyn M. Thomas, et al.. (2009). Analogues of the Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Antagonist Ned-19 Indicate Two Binding Sites on the NAADP Receptor. Journal of Biological Chemistry. 284(50). 34930–34934. 36 indexed citations
13.
Ganesan, A.. (2008). The impact of natural products upon modern drug discovery. Current Opinion in Chemical Biology. 12(3). 306–317. 442 indexed citations
14.
Doi, Takayuki, et al.. (2007). Total Synthesis of Spiruchostatin A. 2006. 5. 1 indexed citations
15.
Packham, Graham, et al.. (2004). Posters. British Journal of Cancer. 91(S1). S61–S69. 1 indexed citations
16.
McWilliams, Daniel F., et al.. (2003). Inflammation and angiogenesis in osteoarthritis. Arthritis & Rheumatism. 48(8). 2173–2177. 313 indexed citations
17.
Ganesan, A.. (2002). Recent developments in combinatorial organic synthesis. Drug Discovery Today. 7(1). 47–55. 48 indexed citations
18.
Wang, Haishan & A. Ganesan. (2000). Total Synthesis of the Fumiquinazoline Alkaloids:  Solution-Phase Studies1. The Journal of Organic Chemistry. 65(4). 1022–1030. 64 indexed citations
19.
Ganesan, A., et al.. (1998). Solid-phase synthesis of peptidomimetic oligomers with a phosphodiester backbone. Bioorganic & Medicinal Chemistry Letters. 8(5). 511–514. 11 indexed citations
20.
Yeo, Su Ling, et al.. (1998). Solid-phase synthesis of potential protein tyrosine phosphatase inhibitors via the Ugi four-component condensation. Bioorganic & Medicinal Chemistry Letters. 8(18). 2443–2446. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liangren Zhang Breakdown of academic impact, for papers by Michael Gütschow Breakdown of academic impact, for papers by Wolfgang Sippl Breakdown of academic impact, for papers by Hengming Ke Breakdown of academic impact, for papers by Mark D. Erion Breakdown of academic impact, for papers by Manfred Jung Breakdown of academic impact, for papers by Matthias U. Kassack Breakdown of academic impact, for papers by Billy W. Day Breakdown of academic impact, for papers by Jeffrey D. Winkler Breakdown of academic impact, for papers by Satoshi Shuto
Rankless by CCL
2026